Therefore, there is a possibility that PARP inhibitor simultaneously suppresses TGF‐β signaling through production of phosphorylated IRF3 by TBK1, and this can be one of the mechanisms of cancer cell death by PARP inhibitor. The gene discussed is TGFB1; the disease is cancer.